EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Development of Tofacitinib Loaded pH-Responsive Chitosan/Mucin Based Hydrogel Microparticles: In-Vitro Characterization and Toxicological Screening

Rania T Malatani iD, Sana Bilal, Asif Mahmood iD, Rai Muhammad Sarfraz iD, Nadiah Zafar, Hira Ijaz iD, Umaira Rehman, Shehla Akbar iD, Hala M Alkhalidi, Heba A Gad iD

Gels · 28.02.2023 · 9 (3) · 187

DOI: 10.3390/gels9030187 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Gels, online erschienen am 28.02.2023. Verfasst von Rania T Malatani und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy Practice, Faculty of Pharmacy, King Abdulaziz University, Jeddah 21589, Saudi Arabia. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 72 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: The Deanship of Scientific Research (DSR) at King Abdulaziz University, Jeddah, Saudi Arabia funded this project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Tofacitinib is an antirheumatic drug characterized by a short half-life and poor permeability, which necessitates the development of sustained release formulation with enhanced permeability potential. To achieve this goal, the free radical polymerization technique was employed to develop mucin/chitosan copolymer methacrylic acid (MU-CHI-Co-Poly (MAA))-based hydrogel microparticles. The developed hydrogel microparticles were characterized for EDX, FTIR, DSC, TGA, X-ray diffraction, SEM, drug loading; equilibrium swelling (%), in vitro drug release, sol–gel (%) studies, size and zeta potential, permeation, anti-arthritic activities, and acute oral toxicity studies. FTIR studies revealed the incorporation of the ingredients into the polymeric network, while EDX studies depicted the successful loading of tofacitinib into the network. The thermal analysis confirmed the heat stability of the system. SEM analysis displayed the porous structure of the hydrogels. Gel fraction showed an increasing tendency (74–98%) upon increasing the concentrations of the formulation ingredients. Formulations coated with Eudragit (2% w/w) and sodium lauryl sulfate (1% w/v) showed increased permeability. The formulations equilibrium swelling (%) increased (78–93%) at pH 7.4. Maximum drug loading and release (%) of (55.62–80.52%) and (78.02–90.56%), respectively, were noticed at pH 7.4, where the developed microparticles followed zero-order kinetics with case II transport. Anti-inflammatory studies revealed a significant dose-dependent decrease in paw edema in the rats. Oral toxicity studies confirmed the biocompatibility and non-toxicity of the formulated network. Thus, the developed pH-responsive hydrogel microparticles seem to have the potential to enhance permeability and control the delivery of tofacitinib for the management of rheumatoid arthritis.

Schlagwörter

Stichwörter der Autor:innen

arthritischitosanmucinpermeationtofacitinib

Autor:innen und Institutionen

  • Department of Pharmacy Practice, Faculty of Pharmacy, King Abdulaziz University, Jeddah 21589, Saudi Arabia.
  • Faculty of Pharmacy, The University of Lahore, Lahore 54000, Pakistan.
  • Department of Pharmacy, University of Chakwal, Chakwal 48800, Pakistan.
  • College of Pharmacy, University of Sargodha, Sargodha 40100, Pakistan.
  • Department of Pharmaceutics, Faculty of Pharmacy, Universiti Teknologi MARA, Puncak Alam Campus, Bandar, PuncakAlam 42300, Malaysia.
  • Department of Pharmaceutical Sciences, Pak-Austria Fachhochschule: Institute of Applied Sciences and Technology, Mang, Khanpur Road, Haripur 22620, Pakistan.

ORCID-Profile: Rania T Malatani, Asif Mahmood, Rai Muhammad Sarfraz, Hira Ijaz, Shehla Akbar, Heba A Gad

Förderung

  • The Deanship of Scientific Research (DSR) at King Abdulaziz University, Jeddah, Saudi Arabia funded this project

Zitieren

APA

Malatani, R. T., Bilal, S., Mahmood, A., Sarfraz, R. M., Zafar, N., Ijaz, H., Rehman, U., Akbar, S., Alkhalidi, H. M., & Gad, H. A. (2023). Development of Tofacitinib Loaded pH-Responsive Chitosan/Mucin Based Hydrogel Microparticles: In-Vitro Characterization and Toxicological Screening. Gels, 9(3), 187. https://doi.org/10.3390/gels9030187

Vancouver

Malatani RT, Bilal S, Mahmood A, Sarfraz RM, Zafar N, Ijaz H, et al. Development of Tofacitinib Loaded pH-Responsive Chitosan/Mucin Based Hydrogel Microparticles: In-Vitro Characterization and Toxicological Screening. Gels. 2023;9(3):187. doi:10.3390/gels9030187

BibTeX
@article{Malatani2023,
  author = {Malatani, Rania T and Bilal, Sana and Mahmood, Asif and Sarfraz, Rai Muhammad and Zafar, Nadiah and Ijaz, Hira and Rehman, Umaira and Akbar, Shehla and Alkhalidi, Hala M and Gad, Heba A},
  title = {Development of Tofacitinib Loaded pH-Responsive Chitosan/Mucin Based Hydrogel Microparticles: In-Vitro Characterization and Toxicological Screening},
  journal = {Gels},
  year = {2023},
  volume = {9},
  number = {3},
  pages = {187},
  doi = {10.3390/gels9030187}
}
Kostenlos starten →